Share This

Public company info - Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. - H Shares , 01349.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. - H Shares, 01349.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12 2015-12 2014-12 2013-12 2012-12 2011-12 2010-12 2009-12 2008-12
Net Cash Flow from Operating Activities 233,929 337,018 179,091 378,966 268,853 66,637 163,166 115,568 106,223 107,084 123,565 53,461 -4,709 9,863 -14,866
Net Cash Flow from Return on Investments & Servicing of Finance -71,039 -52,150 -69,766 -70,198 -34,181 -50,153 -28,275 -50,064 -1,006 -3,483 -5,261 -3,872 -2,399 -2,139 -897
　Interest Received 0 0 0 0 0 2,076 3,773 2,919 864 1,957 905 990 547 406 586
　Interest Paid 0 0 0 0 0 -6,079 -4,062 -7,129 -1,870 -5,440 -6,166 -4,862 -2,946 -2,545 -1,483
　Dividend Received 0 0 0 0 -34,181 0 0 0 0 0 0 0 0 0 0
　Dividend Paid -71,039 -52,150 -69,766 -70,198 0 -46,150 -27,986 -45,854 0 0 0 0 0 0 0
　Others 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Taxes (Paid) / Refunded -68,660 -68,118 -66,087 -109,734 -89,015 -19,923 -22,303 -15,062 -16,858 -14,159 -8,116 0 0 0 0
Net Cash Flow from Investing Activities -96,748 -355,671 -46,535 -21,142 -48,037 -64,565 -47,197 -61,872 -42,189 -58,555 -114,928 -35,155 2,185 -50,993 -1,109
　Additions to Fixed Assets -87,304 -120,116 -42,411 -40,386 -38,963 -55,444 -46,273 -38,250 -44,089 -56,716 -114,605 -32,988 -9,406 -55,791 -2,916
　Disposal of Fixed Assets 1,442 1,706 12,026 2,618 2,248 1,153 586 2,233 545 1,232 36 14 11,312 27 29
　Increase in Investments 0 -265,959 -36,000 0 -24,000 -1,620,660 -1,295,550 -1,790,215 -1,411,817 -422,400 -4,757 -3,422 -7,868 -6,568 -10,627
　Decrease in Investments 0 6,340 0 6,796 0 1,619,105 1,302,133 1,776,817 1,418,590 424,552 5,669 4,437 8,147 11,364 6,199
　Net Cash Flow with Related Parties 0 0 0 0 12,294 5,165 4,990 11,630 0 0 3,100 0 0 68,816 30,000
　Others -10,886 22,358 19,850 9,830 384 -13,884 -13,083 -24,087 -5,418 -5,223 -4,371 -3,196 0 -68,841 -23,794
Net Cash Flow before Financing Activities -2,518 -138,921 -3,298 177,893 97,620 -68,004 65,391 -11,430 46,170 30,887 -4,740 14,434 -4,923 -43,269 -16,872
Net Cash Flow from Financing Activities 82,647 -49,014 823,613 -189,372 22,294 25,165 -10 101,330 -15,000 135,773 52,938 5,330 8,330 80,816 40,000
　New Loans 101,000 0 51,057 151,568 150,000 140,000 180,000 185,000 0 15,000 96,998 60,000 27,000 32,000 10,000
　Loans Repayment 0 0 -200,000 -150,000 -140,000 -120,000 -185,000 -95,300 -15,000 -101,498 -47,160 -54,670 -18,670 -20,000 0
　Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
　Equity Financing 0 0 0 0 0 0 0 0 0 222,271 0 0 0 0 0
　Net Cash Flow with Related Parties 0 0 0 0 12,294 5,165 4,990 11,630 0 0 3,100 0 0 68,816 30,000
　Others -18,353 -49,014 972,556 -190,940 0 0 0 0 0 0 0 0 0 0 0
Increase(Decrease) in Cash & Cash Equivalents 80,129 -187,935 820,315 -11,478 119,914 -42,839 65,381 89,900 31,170 166,660 48,198 19,764 3,407 37,547 23,128
Cash & Cash Equivalents at Beginning of Year 1,208,881 1,396,890 576,799 588,221 468,143 511,284 445,997 356,097 324,927 158,267 110,069 90,305 86,898 49,351 26,280
Net Cash Flow due to Change in Exchange Rate/Others 293 -74 -224 56 164 -301 -94 0 0 0 0 0 0 0 -57
Cash & Cash Equivalents at End of Year 1,289,303 1,208,881 1,396,890 576,799 588,221 468,144 511,284 445,997 356,097 324,927 158,267 110,069 90,305 86,898 49,351
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit Thousand Thousand Thousand Thousand
Auditor's Opinion 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.